Jeremy Grantham Surface Oncology, Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$6.45 - $9.09 $513,342 - $723,454	-79,588 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$7.25 - $13.82 $1.25 Million - $2.38 Million	-172,412 Reduced 68.42%	79,588 $621,000
Q4 2020 Feb 12, 2021	BUY	$6.87 - $10.48 $1.73 Million - $2.64 Million	252,000 New	252,000 $2.33 Million

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.